Corpus

Corpus is a biotechnology company developing a high-resolution map of the human body at the single-cell level to drive the discovery of next-generation therapeutics. By integrating high-throughput single-cell sequencing, spatial proteomics, and advanced computational modeling, the company identifies unique cellular states and molecular drivers of disease that are often invisible to traditional bulk analysis methods. Corpus focuses on uncovering novel drug targets and biomarkers across diverse therapeutic areas, with an initial emphasis on oncology and immunology. The company's platform aims to provide a granular understanding of human biology to enable the development of highly precise and effective medicines.